1
|
Marques A, Rieu I, Pereira B, Castelnovo G, Fluchère F, Laurencin C, Degos B, Poujois A, Kreisler A, Sangla S, Tir M, Benatru I, Blanchet-Fourcade G, Guehl D, Gayraud D, Tatu L, Tranchant C, Simonetta-Moreau M, Durif F. French validation of the Quality of life in Essential Tremor Questionnaire (QUEST) and the Essential Tremor Embarrassment Assessment (ETEA). Rev Neurol (Paris) 2023; 179:1128-1133. [PMID: 37735016 DOI: 10.1016/j.neurol.2023.03.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Revised: 01/30/2023] [Accepted: 03/31/2023] [Indexed: 09/23/2023]
Abstract
Two scales have been developed and validated in English to evaluate the impact of tremor on daily life, namely Quality of life in Essential Tremor Questionnaire (QUEST) and Essential Tremor Embarrassment Assessment (ETEA). The psychometric properties of the French version of these two scales were assessed for 117 patients with head tremor. Both scales showed excellent acceptability, very good internal consistency (Cronbach's alpha coefficient>0.8) and reproducibility (Lin concordance coefficient>0.8), satisfactory external validity and satisfactory sensitivity to change. In conclusion, the French versions of QUEST and ETEA are comprehensive, valid and reliable instruments for assessing patients with head tremor.
Collapse
Affiliation(s)
- A Marques
- Department of Neurology, CHU de Clermont-Ferrand, université Clermont-Auvergne, CNRS, institut Pascal, place Henri-Dunant, 63000 Clermont-Ferrand, France.
| | - I Rieu
- Department of Neurology, CHU de Clermont-Ferrand, université Clermont-Auvergne, CNRS, institut Pascal, place Henri-Dunant, 63000 Clermont-Ferrand, France
| | - B Pereira
- Clinical Research Department, Biostatistics Unit, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France
| | - G Castelnovo
- Service de neurologie, centre hospitalier universitaire Caremeau, 30029 Nîmes, France
| | - F Fluchère
- Department of Neurology and Movement Disorders, Timone Hospital, Aix-Marseille université, 13005 Marseille, France
| | - C Laurencin
- Lyon Neuroscience Research Center, Inserm, U 1028, CNRS, UMR 5292, Neuroplasticity and Neuropathology of Olfactory Perception team, université de Lyon, université Claude-Bernard Lyon 1, 69000 Lyon, France; Service de neurologie C, hospices civils de Lyon (HCL), Pierre-Wertheimer Neurological Hospital, 69000 Lyon, France
| | - B Degos
- Service de neurologie, hôpital Avicenne, AP-HP, université Sorbonne Paris Nord, 93000 Bobigny, France; Dynamics and Pathophysiology of Neuronal Networks Team, Center for Interdisciplinary Research in Biology, collège de France, CNRS UMR7241/Inserm U1050, université Paris sciences & lettres (PSL), 75005 Paris, France
| | - A Poujois
- Service de neurologie, hôpital Fondation Adolphe de Rothschild, 75019 Paris, France
| | - A Kreisler
- Service de neurologie A, Movement Disorders Unit, CHU de Lille, 59037 Lille, France
| | - S Sangla
- Unité Parkinson, hôpital Adolphe de Fondation Rothschild, 75019 Paris, France
| | - M Tir
- Department of Neurology and the Department of Neurosurgery, Expert Centre for Parkinson's Disease, Amiens University Hospital, 80054 Amiens, France; EA 4559 laboratoire de neurosciences fonctionnelles et pathologie (LNFP), University of Picardy Jules-Verne (UPJV), 80054 Amiens, France
| | - I Benatru
- Department of Neurology, University Hospital of Poitiers, 86000 Poitiers, France; Centre d'investigation clinique CIC1402, CHU de Poitiers, University of Poitiers, Inserm, 86000 Poitiers, France
| | | | - D Guehl
- Centre hospitalier universitaire de Bordeaux, institut des maladies neurodégénératives, CNRS, University of Bordeaux, 33000 Bordeaux, France
| | - D Gayraud
- Service de neurologie, centre hospitalier intercommunal Aix-Pertuis, site d'Aix-en-Provence, avenue des Tamaris, 13616 Aix-en-Provence, France
| | - L Tatu
- Department of Neuromuscular Diseases and Department of Anatomy, CHRU de Besançon, University of Franche-Comté, 25030 Besançon, France
| | - C Tranchant
- Department of Neurology, CHU Hautepierre, 67000 Strasbourg, France
| | - M Simonetta-Moreau
- Department of Neurology, Clinical Investigation Center (CIC 1436), Toulouse University Hospital, Inserm (ToNIC 1214), 31059 Toulouse, France
| | - F Durif
- Department of Neurology, CHU de Clermont-Ferrand, université Clermont-Auvergne, CNRS, institut Pascal, place Henri-Dunant, 63000 Clermont-Ferrand, France
| |
Collapse
|
2
|
Grimaldi S, Renaud M, Robert D, Lagier A, Somma H, Soulayrol S, Korchia D, Fluchère F, Lagha-Boukbiza O, Schaeffer M, Witjas T, Azulay JP, Eusebio A. Prevalence and characterisation of vocal fold motion impairment (VFMI) in patients with Multiple system atrophy compared with Parkinson's disease. Rev Neurol (Paris) 2020; 176:608-613. [PMID: 32164972 DOI: 10.1016/j.neurol.2020.01.351] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2019] [Revised: 12/22/2019] [Accepted: 01/02/2020] [Indexed: 01/23/2023]
Abstract
INTRODUCTION Multiple system atrophy (MSA) is a neurodegenerative disorder in which vocal fold mobility can be affected, sometimes leading to life-threatening situations. Our aim was to know if laryngeal examination could help differentiate MSA from Parkinson's disease (PD). MATERIALS AND METHODS Between 2004 to 2014, all consecutive patients diagnosed with probable MSA were included in this retrospective, monocentric study. Flexible laryngoscopy was obtained in 51 MSA patients and compared with 27 patients with Parkinson's disease (PD). Laryngeal muscles EMG was available in 6 MSA patients. RESULTS Vocal fold motion impairments (VFMI) was found in 35 (68.6%) MSA patients: 15 (29.4%) had uni- or bilateral vocal fold abnormal movement (VFAM), 13 (25.5%) had uni- or bilateral vocal fold abductor paresis (VFABP), 4 (7.8%) had uni- or bilateral vocal fold adductor paresis (VFADP), 10 (19.6%) had bilateral vocal fold paralysis (BVFP). VFMI was found in 13 PD patients (48.1%) all of whom had VFADP. Presence of BVFP was found associated with stridor (P<0.001) and dysphagia (P=0.002). In all muscles examined in 6 MSA patients, the EMG showed neuropathic patterns. CONCLUSIONS Our data support that VFMI may be encountered in two-thirds of MSA with a variable degree of gravity. Laryngological examination should be considered as a supplementary tool for the diagnosis and prognosis of MSA. VFMI in particular VFAM, VFABD and BVFP should be discussed as an additional possible red flag even at an early stage of MSA and could help discriminate MSA from PD.
Collapse
Affiliation(s)
- S Grimaldi
- Department of Neurology and Movement Disorders APHM Timone, 13005 Marseille, France.
| | - M Renaud
- Service de génétique clinique, hôpitaux de Brabois, CHU de Nancy, 54500 Vandœuvre-lès-Nancy, France.
| | - D Robert
- Otolaryngology, APHM Conception, 13005 Marseille, France.
| | - A Lagier
- Otolaryngology, APHM Conception, 13005 Marseille, France.
| | - H Somma
- Department of Clinical Neurophysiology, APHM Nord, 13015 Marseille, France.
| | - S Soulayrol
- Department of Neurology and Movement Disorders APHM Timone, 13005 Marseille, France.
| | - D Korchia
- Otolaryngology, APHM Conception, 13005 Marseille, France.
| | - F Fluchère
- Department of Neurology and Movement Disorders APHM Timone, 13005 Marseille, France.
| | - O Lagha-Boukbiza
- Department of Neurology, CHRU Strasbourg, 67098 Strasbourg, France.
| | - M Schaeffer
- Département d'informations médicales, CHRU Strasbourg, 67098 Strasbourg, France.
| | - T Witjas
- Department of Neurology and Movement Disorders APHM Timone, 13005 Marseille, France.
| | - J-P Azulay
- Department of Neurology and Movement Disorders APHM Timone, 13005 Marseille, France.
| | - A Eusebio
- Department of Neurology and Movement Disorders APHM Timone, 13005 Marseille, France.
| |
Collapse
|
3
|
Poujois A, Trocello JM, Djebrani-Oussedik N, Poupon J, Collet C, Girardot-Tinant N, Sobesky R, Habès D, Debray D, Vanlemmens C, Fluchère F, Ory-Magne F, Labreuche J, Preda C, Woimant F. Exchangeable copper: a reflection of the neurological severity in Wilson's disease. Eur J Neurol 2016; 24:154-160. [PMID: 27739240 DOI: 10.1111/ene.13171] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2016] [Accepted: 08/29/2016] [Indexed: 01/13/2023]
Abstract
BACKGROUND AND PURPOSE The severity of Wilson's disease (WD) is linked to free copper accumulating in the liver and brain. Exchangeable copper (CuEXC) is a new technique to determine plasmatic copper and is useful in the diagnosis of WD. It is hypothesized that it may also enable a good evaluation of extra-hepatic involvement and its severity. METHODS Forty-eight newly diagnosed WD patients were prospectively evaluated using hepatic, neurological, ophthalmological and brain magnetic resonance imaging (MRI) scores. Three phenotypic presentations were distinguished: pre-symptomatic, hepatic and extra-hepatic. CuEXC was determined in addition to standard copper assays before decoppering therapy. Correlations between biological parameters and the different scores were determined and compared in the hepatic and extra-hepatic groups. RESULTS Extra-hepatic patients had significantly higher CuEXC values than those with the hepatic form (P < 0.0001). The overall ability of CuEXC to separate the two forms was satisfactory, with an area under the curve of 0.883 (95% confidence interval 0.771-0.996) and an optimal threshold for extra-hepatic diagnosis of 2.08 μmol/l (sensitivity 85.7%; specificity 94.1%). In extra-hepatic patients, CuEXC was the only biological marker to be positively correlated with the Unified Wilson Disease Rating Score (r = 0.45, P = 0.016), the Kayser-Fleischer ring score (r = 0.46, P = 0.014) and the brain MRI score (r = 0.38, P = 0.048), but it was not correlated with the hepatic score. CONCLUSIONS Exchangeable copper determination is useful when diagnosing WD as a value >2.08 μmol/l is indicative of the severity of the extra-hepatic involvement. In the case of purely hepatic presentation, atypical or mild neurological signs, it should encourage physicians to search for lesions in the brain and eyes.
Collapse
Affiliation(s)
- A Poujois
- National Reference Centre for Wilson's Disease, AP-HP, Lariboisière Hospital, Paris, France.,Neurology Department, AP-HP, Lariboisière Hospital, Paris, France
| | - J-M Trocello
- National Reference Centre for Wilson's Disease, AP-HP, Lariboisière Hospital, Paris, France.,Neurology Department, AP-HP, Lariboisière Hospital, Paris, France
| | - N Djebrani-Oussedik
- National Reference Centre for Wilson's Disease, AP-HP, Lariboisière Hospital, Paris, France.,Toxicology Laboratory, AP-HP, Lariboisière Hospital, Paris, France
| | - J Poupon
- National Reference Centre for Wilson's Disease, AP-HP, Lariboisière Hospital, Paris, France.,Toxicology Laboratory, AP-HP, Lariboisière Hospital, Paris, France
| | - C Collet
- National Reference Centre for Wilson's Disease, AP-HP, Lariboisière Hospital, Paris, France.,Molecular Biology and Biochemistry Department, AP-HP, Lariboisière Hospital, Paris, France
| | - N Girardot-Tinant
- National Reference Centre for Wilson's Disease, AP-HP, Lariboisière Hospital, Paris, France.,Neurology Department, AP-HP, Lariboisière Hospital, Paris, France
| | - R Sobesky
- National Reference Centre for Wilson's Disease, AP-HP, Lariboisière Hospital, Paris, France.,Hepatobiliary Centre, DHU Hepatinov, AP-HP, Paul Brousse Hospital, Villejuif, France
| | - D Habès
- National Reference Centre for Wilson's Disease, AP-HP, Lariboisière Hospital, Paris, France.,Hepatology and Pediatrics Department, AP-HP, Kremlin-Bicètre Hospital, Kremlin-Bicètre, France
| | - D Debray
- Hepatology and Pediatrics Department, AP-HP, Necker Hospital, Paris, France
| | - C Vanlemmens
- Hepatology and Gastroenterology Department, CHU Besancon, Besancon, France
| | - F Fluchère
- Neurology Department, CHU Marseille, Marseille, France
| | - F Ory-Magne
- Neurology Department, CHU Toulouse, Toulouse, France
| | - J Labreuche
- Biostatistics Unit, EA2694, CHRU Lille, Lille, France
| | - C Preda
- Mathematics Laboratory, UMR CNRS 8524, Lille, France
| | - F Woimant
- National Reference Centre for Wilson's Disease, AP-HP, Lariboisière Hospital, Paris, France.,Neurology Department, AP-HP, Lariboisière Hospital, Paris, France
| |
Collapse
|
4
|
Poujois A, Djebrani-Oussedik N, Sobesky R, Tinant N, Collet C, Habès D, Debray D, Vanlemmens C, Fluchère F, Ory-Magne F, Labreuche J, Duclos-Vallée JC, Poupon J, Woimant F. Cuivre échangeable : un reflet de la sévérité de l’atteinte extra-hépatique dans la maladie de Wilson. Arch Pediatr 2016. [DOI: 10.1016/j.arcped.2016.07.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
5
|
Azulay JP, Fluchère F, Soulayrol S, Tourlet C, Beaulieu JP, Somma H. Intérêt du traitement par toxine botulique des troubles de l’orientation posturale chez le parkinsonien. Neurophysiol Clin 2012. [DOI: 10.1016/j.neucli.2012.09.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
6
|
Caudron S, Guerraz M, Eusebio A, Witjas T, Fluchère F, Azulay JP, Vaugoyeau M. Visualiser en temps réel sa géométrie corporelle permet-il d’améliorer la stabilisation et l’orientation posturale chez le patient parkinsonien ? Neurophysiol Clin 2012. [DOI: 10.1016/j.neucli.2012.09.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
7
|
Witjas T, Eusebio A, Fluchère F, Azulay JP. Addictive behaviors and Parkinson's disease. Rev Neurol (Paris) 2012; 168:624-33. [DOI: 10.1016/j.neurol.2012.06.014] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2012] [Revised: 06/28/2012] [Accepted: 06/28/2012] [Indexed: 10/28/2022]
|